Latest1 information on COVID-19
©2022 Stanford Medicine
Recruiting
I'm InterestedTrial ID: NCT04193878
ARrest RESpiraTory Failure From PNEUMONIA (ARREST PNEUMONIA)
Associate Professor of Medicine (Pulmonary and Critical Care Medicine)
Associate Professor of Medicine (Pulmonary and Critical Care)
Clinical Associate Professor, Emergency Medicine
Inclusion Criteria:
Patients 18 years or older with
1. Severe Pneumonia defined as hospitalization for acute (defined as ≤ 14 days) onset of
symptoms (cough, sputum production, or dyspnea) and radiographic evidence of pneumonia
by chest radiograph or CT scan AND evidence of systemic inflammation (temperature <
35◦C or > 38◦C OR WBC > or < upper or lower limits for site OR procalcitonin > 0.5
mcg/L), OR known current immunosuppression preventing inflammatory response.
AND
2. Hypoxemia defined as new requirement for daytime supplemental oxygen with SpO2 < 92%
on room air, ≤ 96% on ≥ 2 L/min oxygen, or > 6L/min or non-invasive ventilation
regardless of SpO2 at enrollment. Patients admitted with pneumonia but not meeting
criteria for hypoxemia will be followed for up to 24 hours from ED admission to
enrolling hospital to assess for development of qualifying hypoxemia.
Exclusion Criteria:
1. Inability to obtain consent within 24 hours of presentation to enrolling hospital (up
to 12 hours allowed at transferring ED for maximum of 36 hours from presentation)
2. Intubation (or impending intubation) prior to enrollment
a. Patients receiving HFNC oxygen or NIV prior to enrollment are not excluded
3. A condition requiring inhaled corticosteroids or beta-agonists (patients receiving
inhaled beta-agonists in the ED without an established indication will be eligible if
treating clinician is willing to discontinue subsequent treatments)
4. Chronic systemic steroid therapy equivalent to >10 mg prednisone
5. COVID-19 positive patients receiving > 6 mg dexamethasone (30 mg prednisone equivalent
dose)
6. Non-COVID-19 pneumonia patients receiving systemic steroid > 10 mg prednisone except
for stress dose steroids for septic shock
7. Chronic lung or neuromuscular disease requiring daytime oxygen or mechanical
ventilation other than for obstructive sleep apnea (OSA) or obesity hypoventilation
syndrome
8. Not anticipated to survive > 48 hours or not expected to require > 48 hours of
hospitalization
9. Contraindication or allergy to inhaled corticosteroids or beta-agonists
10. Patients with heart rate > 130 bpm, ventricular tachycardia or new supraventricular
tachycardia within last 4 hours will be potentially eligible for enrollment after the
condition has resolved
11. K+ < 3.0 will be potentially eligible for enrollment after the condition has resolved
12. Patient not committed to full support other than intubation or resuscitation (i.e.,
DNR/DNI status allowed)
13. Pregnancy
14. Incarcerated individual
15. Physician refusal of consent to protocol
16. Patient/surrogate refusal of consent to protocol
drug: Inhaled budesonide and formoterol
drug: Inhaled placebo
Recruiting
I'm Interested
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Joe Levitt, MD
650-723-6381